SRTS's logo.
Ticker Symbol: SRTS

Sensus Healthcare Inc

$5.55 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001494891

Company Profile

Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions. The Sculptura™ modulated robotic brachytherapy radiation oncology system provides targeted Directional Anisotropic Radiation Therapy (ART) and Brachytherapy utilizing its proprietary, state-of-the-art 3D Beam Sculpting™ to treat patients undergoing cancer treatment during surgery, or at the tumor site, fast and efficiently. Sensus also offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: 851 Broken Sound Pkwy NW Ste 215
CEO: Joseph Sardano
Tags:
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $2.58
Change: -$0.13 ( -4.80%)
Days Range: $2.56 - $2.76
Beta: 0.90
52wk. High: $14.75
52wk. Low: $2.29
Ytd. Change -68.27%
50 Day Moving Average: $2.69
200 Day Moving Average: $3.24
Shares Outstanding: 16391831

Valuation

Market Cap: 4.2B
PE Ratio: 17.77
EPS (TTM): 0.1452

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A